返回提示词目录第 1146 页

梳理医疗器械证据与安全风险

整理器械用途、临床证据与风险控制缺口,形成评审矩阵及监测行动,供专业审查参考。

完整提示词

Main objective:

> Review medical-device evidence across intended use, regulatory status, clinical performance, safety, usability, post-market signals and comparator relevance.

## 1. SYSTEM CONTEXT

Establish care setting, users, patients/population, intended use, workflow, technology/device, handoffs, staffing, governance, regulatory status, data flows, known incidents, current controls and outcome measures.

## 2. SAFETY MODEL

Treat harm as potentially emerging from interacting factors:
- task and workflow design
- human factors and cognitive load
- staffing and workload
- communication / handoff
- technology / UI
- data quality
- environment
- policy / governance
- training and competence
- latent organizational conditions

Do not stop at "human error".

## 3. DIGITAL / AI EVIDENCE GATE

For digital health, medical devices or AI:
- define intended purpose and risk tier
- verify regulatory status where relevant
- assess clinical evidence appropriate to risk
- distinguish technical performance from clinical utility
- inspect dataset/population match
- test subgroup performance and failure modes
- require human oversight and escalation
- assess update / drift / monitoring plan
- evaluate privacy, cybersecurity and workflow integration
- identify automation bias and overreliance risk

Use NICE-type evidence standards as a benchmark where relevant, but do not confuse them with regulatory approval or a universal safety certification. citeturn844627search1turn844627search10

## 4. INCIDENT LEARNING

For incidents:
```text
Event:
Patient impact:
Detection:
Timeline:
Expected process:
Actual process:
Contributing factors:
Failed barriers:
Successful barriers:
Latent conditions:
Immediate actions:
System actions:
Owner:
Verification:
Recurrence indicator:
```

Incident-report data can support learning but may be incomplete and biased; do not use raw report counts as direct incidence estimates. citeturn247019search12

## 5. REQUIRED MATRICES

### Hazard-Control Matrix
| Hazard | Failure mode | Patient impact | Existing control | Evidence | Gap | Action |
|---|---|---|---|---|---|---|

### Workflow Matrix
| Step | Actor | Information | Decision | Handoff | Failure mode | Escalation |
|---|---|---|---|---|---|---|

### Digital Evidence Matrix
| Claim | Intended use | Evidence | Population | Comparator | Outcome | Bias | Monitoring |
|---|---|---|---|---|---|---|---|

## 6. METRICS & LEARNING

Prefer process and outcome measures that have clear definitions, denominators and actionability. Detect gaming, documentation artifacts and risk-adjustment issues. Every corrective action should have an owner, completion evidence and a measure of whether risk actually fell.

## 7. REQUIRED OUTPUT

1. System / intended-use map.
2. Key hazards and failure modes.
3. Patient-impact assessment.
4. Evidence and control gaps.
5. Required matrices.
6. Immediate containment where relevant.
7. Corrective and preventive actions.
8. Monitoring / recurrence indicators.
9. Governance owners and deadlines.
10. Final learning review.

End with **System Safety Check** confirming that findings are systems-based, evidence-linked and converted into measurable safety actions rather than blame.

This supports quality and safety analysis and does not replace required formal clinical, regulatory or medical-device review.

分类与标签

健康生活、医疗器械评审、临床证据、患者安全、风险控制、上市后监测

前往 AI 图片创作